Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:tinidazole
|
gptkbp:activities |
antimicrobial agent
|
gptkbp:appointed_by |
oral tablet
|
gptkbp:approves |
gptkb:1998
gptkb:FDA |
gptkbp:clinical_trial |
Phase III
treatment of infections |
gptkbp:contraindication |
alcohol consumption
severe liver disease hypersensitivity to tinidazole |
gptkbp:counseling_services |
take with food to reduce stomach upset
avoid alcohol during treatment |
gptkbp:dosage_form |
gptkb:tablet
1 gram once daily 2 grams for certain infections |
gptkbp:excretion |
urine
|
gptkbp:formulation |
film-coated tablet
|
https://www.w3.org/2000/01/rdf-schema#label |
Tindamax
|
gptkbp:indication |
bacterial vaginosis
|
gptkbp:ingredients |
gptkb:tinidazole
C7 H9 N3 O3 S |
gptkbp:interacts_with |
gptkb:warfarin
lithium |
gptkbp:is_atype_of |
P01 A B02
|
gptkbp:is_available_on |
gptkb:brand
|
gptkbp:is_effective_against |
effective against anaerobic bacteria
effective against protozoa |
gptkbp:is_monitored_by |
liver function tests
complete blood count |
gptkbp:is_used_for |
bacterial infections
|
gptkbp:lifespan |
12-14 hours
|
gptkbp:manager |
oral
|
gptkbp:manufacturer |
various pharmaceutical companies
|
gptkbp:metabolism |
liver
|
gptkbp:packaging |
blister pack
|
gptkbp:pharmacokinetics |
well absorbed orally
|
gptkbp:previous_name |
gptkb:tinidazole
|
gptkbp:requires |
gptkb:theorem
|
gptkbp:safety_features |
not for use in pregnancy
may cause allergic reactions not for use in breastfeeding |
gptkbp:shelf_life |
2-3 years
|
gptkbp:side_effect |
dizziness
fatigue headache nausea abdominal pain diarrhea rash insomnia metallic taste |
gptkbp:storage |
room temperature
|
gptkbp:treatment |
giardiasis
trichomoniasis amoebiasis |